Baird Medical Investment Holdings Limited
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | $-27.3M | $12.5M | $10.5M | $12.8M |
| Depreciation & Amortization | $1.1M | $1.1M | $1.0M | $916.1K |
| Depreciation | $1.1M | $1.1M | $991.8K | $862.6K |
| Amortization | $8.4K | $8.4K | $22.6K | $53.5K |
| Stock-Based Compensation | $17.5M | — | — | — |
| Net Cash from Operating Activities | $-1.3M | $-6.3M | $-1.0M | $486.0K |
| Investing Activities | ||||
| Capital Expenditures | $42.3K | $2.9M | $2.6M | $5.9M |
| Business Acquisitions | — | — | — | — |
| Net Cash from Investing Activities | $-42.3K | $-2.5M | $-2.7M | $-5.9M |
| Financing Activities | ||||
| Dividends Paid | — | — | — | — |
| Stock Repurchases | — | — | — | — |
| Net Cash from Financing Activities | $-1.4M | $10.3M | $3.5M | $4.4M |
| Net Change in Cash | $-2.4M | $1.5M | $-200.4K | $-1.3M |
| Free Cash Flow | $-1.4M | $-9.2M | $-3.7M | $-5.4M |